Use of this site and material contained on its pages is for EDUCATIONAL USE ONLY.
 
Pharmskills Online - Clinical Pharmacy Reports Activity

Brian Stickle
DEMOGRAPHICS
 
Age: 50
Gender: M
Race: African American
Allergies: NKDA

DIAGNOSIS
 
Primary:
1) Cryptococcal meningitis
2) Human immunodeficiency virus (HIV)

VITAL SIGNS
 
BP 132/89 mmHg
HR 70 bpm
RR 20 rpm
T 99.3°F oral
Ht 6'0"
Wt 264 lb

CURRENT LABS
 
Sodium 140 mEq/L
Potassium 4 mEq/L
Chloride 106 mEq/L
CO2 content 28 mEq/L
BUN 30 mg/dL
Serum creatinine 2.8 mg/dL
Glucose 106 mg/dL
Hemoglobin 16.2 g/dL
Hematocrit 49%
Platelets 281,000/mm3
WBC 20,600/mm3 with 75% PMN, 18% bands, 3% lymphocytes, 4% monocytes
Lymphocyte subset analysis: CD4 cells 380/mm3 , CD8 cells 968/mm3
HIV ultrasensitive PCR assay: HIV RNA 9240 copies/mL
Blood toxicology/alcohol screen: Negative
Head CT: Normal
CXR: Normal
Lumbar puncture/cerebral spinal fluid: WBC 700/mm3, 26% segs, 68% lymphocytes, 6% monocytes, 10 RBCs, glucose 7 mg/dL, protein 490 mg/dL
CSF culture: positive for Cryptococcus neoformans

MEDICATION PROFILE
 
Drug Dose Frequency Admin Times Route
FLUCONAZOLE 400 mg QD 0800 IV
EFAVIRENZ 600 mg QD 2100 PO
LAMIVUDINE 150 mg QD 0800 PO
DIDANOSINE EC 200 mg QD 0800 PO
VITAMIN, MULTIPLE 1 cap QD 0800 PO

Dennis Wheal
DEMOGRAPHICS
 
Age: 57
Gender: M
Race: Caucasian
Allergies: Aspirin (rash)

DIAGNOSIS
 
Primary:
1) Skin infection
2) Shingles
Secondary:
3) Postherpetic neuralgia
4) Transient ischemia

VITAL SIGNS
 
BP 145/86 mmHg
HR 82 bpm
RR 24 rpm
T 98.1°F oral
Ht 5'9"
Wt 230 lb

CURRENT LABS
 
Serum creatinine 3.2 mg/dL

MEDICATION PROFILE
 
Drug Dose Frequency Admin Times Route
ACYCLOVIR 800 mg 5 DOSES/DAY(Q4H) 0600, 1000, 1400, 1800, 2200 PO
GABAPENTIN 600 mg Q8H 0600, 1400, 2200 PO
CEFTAZIDIME 2 g Q8H 0600, 1400, 2200 IV
AGGRENOX 200 mg/25 mg BID 0800, 2000 PO
OXYCODONE/APAP 7.5 mg/500 mg 1 or 2 tabs Q4-6H PRN PRN PO

Gladys Glartock
DEMOGRAPHICS
 
Age: 67
Gender: F
Race: African American
Allergies: Codeine (hives)

DIAGNOSIS
 
Primary:
1) Dyslipidemia
2) Diabetes
Secondary:
3) Diabetic peripheral neuropathy
4) Diabetic gastroparesis

VITAL SIGNS
 
BP 144/90 mmHg
HR 88 bpm
RR 26 rpm
T 97.4°F oral
Ht 5'4"
Wt 205 lb

CURRENT LABS
 
Serum creatinine 2.7 mg/dL
AST 25 IU/L
ALT 19 IU/L

MEDICATION PROFILE
 
Drug Dose Frequency Admin Times Route
ROSUVASTATIN 20 mg DAILY 0800 PO
FENOFIBRATE 67 mg DAILY 0800 PO
METFORMIN 500 mg TID 0800, 1200, 1800 PO
PREGABALIN 300 mg BID 0800, 2000 PO
METOCLOPRAMIDE 10 mg AC&HS 0700, 1100, 1700, 2200 PO

Kendall Stridor
DEMOGRAPHICS
 
Age: 74
Gender: M
Race: Caucasian
Allergies: Sulfa (hives)

DIAGNOSIS
 
Primary:
1) Community-acquired pneumonia

VITAL SIGNS
 
BP 141/66 mmHg
HR 79 bpm
RR 26 rpm
T 99°F oral
Ht 5'8"
Wt 152 lb

CURRENT LABS
 
Serum creatinine 4.1 mg/dL

MEDICATION PROFILE
 
Drug Dose Frequency Admin Times Route
LEVOFLOXACIN 500 mg QD 0800 IV

Lewis Stoole
DEMOGRAPHICS
 
Age: 63
Gender: M
Race: Caucasian
Allergies: NKDA

DIAGNOSIS
 
Primary:
1) Colorectal surgery prophylaxis
Secondary:
2) Ulcerative colitis

VITAL SIGNS
 
BP 124/85 mmHg
HR 68 bpm
RR 23 rpm
T 97.6°F oral
Ht 5'11"
Wt 170 lb

CURRENT LABS
 
Serum creatinine 3.1 mg/dL

MEDICATION PROFILE
 
Drug Dose Frequency Admin Times Route
ERTAPENEM 1 g DAILY 0800 IV
SULFASALAZINE 500 mg Q6H 0600, 1200, 1800, 2400 PO

Luby Duboise
DEMOGRAPHICS
 
Age: 78
Gender: F
Race: Caucasian
Allergies: NKDA

DIAGNOSIS
 
Primary:
1) Hospital-acquired (nosocomial) pneumonia
2) Congestive heart failure
Secondary:
3) Gout

VITAL SIGNS
 
BP 112/60 mmHg
HR 69 bpm
RR 21 rpm
T 98°F oral
Ht 5'7"
Wt 143 lb

CURRENT LABS
 
Serum creatinine 1.2 mg/dL

MEDICATION PROFILE
 
Drug Dose Frequency Admin Times Route
ALLOPURINOL 300 mg QD 0800 PO
DIGOXIN 0.25 mg QD 0800 PO
PIPERACILLIN/TAZOBACTAM 4.5 g Q6H 0600, 1200, 1800, 2400 IV

Ramona Peres
DEMOGRAPHICS
 
Age: 77
Gender: F
Race: Hispanic
Allergies: Penicillin (rash)

DIAGNOSIS
 
Primary:
1) Deep vein thrombosis
Secondary:
2) Hypertension uncontrolled
3) Diabetes mellitus not assessed
4) Alzheimer's disease, significant impairment, poor self-care
5) Open angle glaucoma not assessed
6) Anemia, unknown etiology

VITAL SIGNS
 
BP 162/74 mmHg
HR 72 bpm
RR 21 rpm
T 98°F oral
Ht 5'5"
Wt 170 lb

CURRENT LABS
 
Sodium 143 mEq/L
Potassium 3.7 mEq/L
Chloride 110 mEq/L
CO2 content 26 mEq/L
BUN 13 mg/dL
Serum creatinine 1.1 mg/dL
Glucose 102 mg/dL
Hemoglobin A1c 7.9%
PT 17 sec
INR 1.31
Hemoglobin 12.1 g/dL
Hematocrit 33.6%
Platelets 172,000/mm3
WBC 4.8 k/mm3
RBC 3.96 m/mm3

MEDICATION PROFILE
 
Drug Dose Frequency Admin Times Route
GLIPIZIDE 2.5 mg DAILY 0800 PO
BENAZEPRIL 20 mg DAILY 0800 PO
RISPERIDONE 0.5 mg DAILY 0800 PO
DONEPEZIL 10 mg BEDTIME 2200 PO
BRIMONIDINE TART 0.2% DAILY 0800 OPHTHAL
ASPIRIN E.C. 325 mg DAILY 0800 PO
ENOXAPARIN 80 mg TWICE DAILY 0800, 2000 SUBQ
WARFARIN 10 mg DAILY 0800 PO

Skip Abeatson
DEMOGRAPHICS
 
Age: 49
Gender: M
Race: Hispanic
Allergies: NKDA

DIAGNOSIS
 
Primary:
1) Complicated appendicitis
Secondary:
2) Atrial fibrillation

VITAL SIGNS
 
BP 131/76 mmHg
HR 72 bpm
RR 24 rpm
T 98°F oral
Ht 6'1"
Wt 180 lb

CURRENT LABS
 
Serum creatinine 2.2 mg/dL
PT 25 sec
INR 3.31

MEDICATION PROFILE
 
Drug Dose Frequency Admin Times Route
WARFARIN 2.5 mg DAILY 0800 PO
SOTALOL 80 mg BID 0800, 2000 PO
MEROPENEM 1 g Q8H 0600, 1400, 2200 IV

Virginia Lepew
DEMOGRAPHICS
 
Age: 87
Gender: F
Race: Asian
Allergies: NKDA

DIAGNOSIS
 
Primary:
1) Vaginal trichomoniasis
Secondary:
2) Osteoporosis

VITAL SIGNS
 
BP 101/58 mmHg
HR 61 bpm
RR 20 rpm
T 97.1°F oral
Ht 5'0"
Wt 90 lb

CURRENT LABS
 
Serum creatinine 4.5 mg/dL

MEDICATION PROFILE
 
Drug Dose Frequency Admin Times Route
ALENDRONATE 10 mg DAILY 0800 PO
DOXYCYCLINE 100 mg Q12H 0800, 2200 PO
METRONIDAZOLE 500 mg Q12H 0800, 2200 PO

Quick Links
Renal Function CalculatorNormal Lab ValuesAntibiogramsLexi-Comp Online

Run Clinical Report
 

 
Patient Name Report Code Agent
Brian Stickle A A0001 LOOK FOR C & S RESULTS
Dennis Wheal A A0001 LOOK FOR C & S RESULTS
Kendall Stridor A A0001 LOOK FOR C & S RESULTS
Lewis Stoole A A0001 LOOK FOR C & S RESULTS
Luby Duboise A A0001 LOOK FOR C & S RESULTS
Skip Abeatson A A0001 LOOK FOR C & S RESULTS
Virginia Lepew A A0001 LOOK FOR C & S RESULTS
Patient Name Report Code Agent
Dennis Wheal C C0009 AGGRENOX (ASA,DIPYRIDAMOLE)
MONITOR INR,PT
Ramona Peres C C0001 WARFARIN (COUMADIN)
MONITOR INR, PT OR PTT
Ramona Peres C C0005 ENOXAPARIN (LOVENOX)
MONITOR INR, PT OR PTT
Ramona Peres C C0003 ASPIRIN
MONITOR INR, PT OR PTT
Skip Abeatson C C0001 WARFARIN (COUMADIN)
MONITOR INR, PT OR PTT
Patient Name Report Code Agent
Gladys Glartock D D0001 DIABETIC MEDICATION
Ramona Peres D D0001 DIABETIC MEDICATION
Ramona Peres D D0002 ATYPICAL ANTIPSYCHOTIC
MONITOR FOR HYPERGLYCEMIA
Patient Name Report Code Agent
Gladys Glartock F F0011 GRAPEFRUIT JUICE
DESCRIPTION WHILE ON THIS DRUG AVOID GRAPEFRUIT AND GRAPEFRUIT JUICE.
Ramona Peres F F0001 VITAMIN K FOODS
AVOID FOODS WITH HIGH LEVELS OF VITAMIN K.
Skip Abeatson F F0001 VITAMIN K FOODS
AVOID FOODS WITH HIGH LEVELS OF VITAMIN K.
Skip Abeatson F F0011 GRAPEFRUIT JUICE
DESCRIPTION WHILE ON THIS DRUG AVOID GRAPEFRUIT AND GRAPEFRUIT JUICE.
Virginia Lepew F F0031 ALENDRONATE ON EMPTY STOM
TAKE FOSAMAX 30MIN BEFORE FIRST BITE OF FOOD, BEVERAGE, OR DRUG OF THE DAY. SIT UP FOR 30 MINUTES AFTER TAKING FOSAMAX
Virginia Lepew F F0009 DAIRY FOODS
DAIRY FOODS REDUCE ABSORPTION. TAKE 1 HR BEFORE OR 2HR AFTER DAIRY FOODS.
Patient Name Report Code Agent
Gladys Glartock H H0008 FENOFIBRATE (TRICOR)
REGULAR PERIODIC MONITORING FOR DURATION OF THERAPY. IF LFTS ARE >3 TIMES ULN, STOP DRUG.
Gladys Glartock H H0005 ROSUVASTATION (CRESTOR)
BASELINE LFT AT 2, 12 WEEKS AFTER INITIATION OR DOSE INCREASE & Q6 MONTHS. IF LFT INCREASE, REPEAT TESTS UNTIL RETURN TO NORMAL. IF >3 TIMES ULN OCCURS AND PERSISTS, STOP DRUG. ABNORMALITIES USUALLY OCCUR IN FIRST 3 MONTHS.
Patient Name Report Code Agent
Patient Name Report Code Agent
Dennis Wheal P P0001 PAIN MED CLINICAL MONITORING
MONITOR PAIN MED USAGE
Patient Name Report Code Agent
Dennis Wheal S S0012 PATIENT SAFETY GOALS:NARCOTIC
PATIENT ON ANARCOTIC/ANALGESIC IF NARC/ANALGESIC CAUSES SOMNOLENCE--PT MAY BE AT INCREASED RISK FOR FALLS SCORE = 1
Dennis Wheal S S0009 PATIENT SAFETY GOALS:ANTI-CONV
ANTI-CONVULSANTS MAY CAUSE ATAXIA AND BONE LOSS. PATIENT MAY BE AT AN INCREASE RISK FOR FALLS. SCORE = 1
Gladys Glartock S S0009 PATIENT SAFETY GOALS:ANTI-CONV
ANTI-CONVULSANTS MAY CAUSE ATAXIA AND BONE LOSS. PATIENT MAY BE AT AN INCREASE RISK FOR FALLS. SCORE = 1
Ramona Peres S S0015 PT SAFETY GOALS:ATYP. ANTIPSYC
PT ON ATYPICAL ANTIPSYCHOTIC MAY BE AT INCREASED RISK FOR FALL. SCORE = 3
Patient Name Report Code Agent
Brian Stickle R R0083 FLUCONAZOLE (DIFLUCAN)
Dennis Wheal R R0024 GABAPENTIN (NEURONTIN)
Dennis Wheal R R0067 CEFTAZIDIME (TAZIDIME,FORTAZ)
Dennis Wheal R R0093 ACYCLOVIR (ZOVIRAX)
Gladys Glartock R R0032 METOCLOPRAMIDE (REGLAN)
Gladys Glartock R R0140 FENOFIBRATE (TRICOR)
Gladys Glartock R R0133 PREGABALIN (LYRICA)
Gladys Glartock R R0030 METFORMIN (GLUCOPHAGE)
Gladys Glartock R R0131 ROSUVASTATIN (CRESTOR)
Kendall Stridor R R0031 LEVOFLOXACIN (LEVAQUIN)
Lewis Stoole R R0136 ERTAPENEM (INVANZ)
Lewis Stoole R R0055 SULFASALAZINE (AZULFIDINE)
Luby Duboise R R0002 ALLOPURINOL (ZYLOPRIM)
Luby Duboise R R0016 DIGOXIN (LANOXIN)
Luby Duboise R R0079 PIP/TAZO (ZOSYN)
Ramona Peres R R0043 RISPERIDONE (RISPERDAL)
Ramona Peres R R0005 BENAZEPRIL (LOTENSIN)
Skip Abeatson R R0062 MEROPENEM (MERONEM)
Skip Abeatson R R0049 SOTALOL (BETAPACE)
Virginia Lepew R R0087 DOXYCYCLINE
Virginia Lepew R R0053 ALENDRONATE (FOSAMAX)
Virginia Lepew R R0033 METRONIDAZOLE (FLAGYL)